Copyright
        ©The Author(s) 2016.
    
    
        World J Clin Infect Dis. Aug 25, 2016; 6(3): 28-36
Published online Aug 25, 2016. doi: 10.5495/wjcid.v6.i3.28
Published online Aug 25, 2016. doi: 10.5495/wjcid.v6.i3.28
            Table 1 Management outline for recurrent Clostridium difficile infection[7]
        
    | General | 
| Stop/minimize antibiotics (if possible, to allow gut flora to repopulate) | 
| Rule out other causes of diarrhea, i.e., post-infectious IBS (check stool for C diff only in context of symptoms, not as test of cure) | 
| Antibiotic treatment | 
| Use the same antibiotic as initial regimen (depending on disease severity and response to initial treatment)[7,52] | 
| Consider Vancomycin taper ± pulse[11] | 
| Vancomycin followed by rifaximin chaser[67] | 
| Fidaxomicin[80] | 
| Probiotics | 
| Probiotics with antibiotics may help[99]. Consider adding to last 2 wk of vancomycin pulse/taper and continue for 4 wk after (caution in immunocompromised patients- may cause fungemia. Don’t use in isolation. Not standardized, doses/active agents may vary) | 
| Immunotherapy | 
| Monoclonal antibody (neutralize toxin)[54] | 
| IVIG[51] | 
| Toxoid vaccine[58] | 
| Non toxigenic strains[42] | 
| Bacteriotherapy | 
| Fecal microbiota transplant[111,114] | 
- Citation: Meehan AM, Tariq R, Khanna S. Challenges in management of recurrent and refractory Clostridium difficile infection. World J Clin Infect Dis 2016; 6(3): 28-36
- URL: https://www.wjgnet.com/2220-3176/full/v6/i3/28.htm
- DOI: https://dx.doi.org/10.5495/wjcid.v6.i3.28

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        